Lotus Pharmaceutical CoTPE:1795 76 Days Inventory is 221.42 as of Dec. 2025, which is 64% above its 10-year median of 135.22. GuruFocus rates TPE:1795 with a GF Score™ of 76/100 and a GF Value™ of NT$451.29 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 919 Drug Manufacturers companies, Lotus Pharmaceutical Co ranks worse than 67.79% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Lotus Pharmaceutical Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.41.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lotus Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 1.08.
Lotus Pharmaceutical Co (TPE:1795) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Lotus Pharmaceutical Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lotus Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Lotus Pharmaceutical Co Days Inventory Related Terms
Lotus Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Lotus Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lotus Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Lotus Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Pharmaceutical Co (TPE:1795) has a Days Inventory of 221.42 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lotus Pharmaceutical Co and its competitors. This is 64% above median its historical median of 135.22. Over the past decade, Lotus Pharmaceutical Co's Days Inventory has ranged from 88.06 to 286.02. According to the industry distribution chart, Lotus Pharmaceutical Co ranks #623 out of 919 companies in the Drug Manufacturers industry, placing it in the top 67.8%.
Is Lotus Pharmaceutical Co's Days Inventory too high?
Lotus Pharmaceutical Co's current Days Inventory of 221.42 is 64% above median its 10-year median of 135.22. Over the past 10 years, this metric has ranged from a low of 88.06 to a high of 286.02. The Drug Manufacturers industry median Days Inventory is 164.38. Lotus Pharmaceutical Co's value of 221.42 is 34.7% above this industry median. Based on the distribution chart, Lotus Pharmaceutical Co ranks #623 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Lotus Pharmaceutical Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lotus Pharmaceutical Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Lotus Pharmaceutical Co ranks #623 out of 919 companies for Days Inventory. This places Lotus Pharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 164.38. Lotus Pharmaceutical Co's value of 221.42 is 34.7% above this benchmark. Historically, Lotus Pharmaceutical Co's own Days Inventory has ranged from 88.06 to 286.02 over the past decade. While the company's 10-year median is 135.22 vs. the industry median of 164.38, Lotus Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lotus Pharmaceutical Co's current Days Inventory of 221.42 is 34.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lotus Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Pharmaceutical Co's current Days Inventory is 221.42, which is 64% above median its own 10-year median of 135.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Lotus Pharmaceutical Co (TPE:1795) is currently considered Possible Value Trap. The stock's GF Value™ is NT$451.29, compared to a current price of NT$204.00 — trading 54.8% below its estimated fair value. The current Days Inventory is 221.42, which is 64% above median its 10-year median of 135.22 and 34.7% above the Drug Manufacturers industry median of 164.38. Lotus Pharmaceutical Co's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Lotus Pharmaceutical Co (TPE:1795), the current Days Inventory is 221.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lotus Pharmaceutical Co (TPE:1795) Overvalued in 2026?
Based on GuruFocus' analysis, Lotus Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$204.00 is trading 54.8% below its estimated GF Value™ of NT$451.29.
GuruFocus considers Lotus Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for TPE:1795:
Days Inventory: 221.42 (64% above median its 10-year median of 135.22)
GF Value™: NT$451.29 vs. price of NT$204.00 (54.8% below fair value)
Industry Position: 34.7% above the Drug Manufacturers median (#623 of 919)
No single metric tells the full story. See the TPE:1795 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. Along with its subsidiaries, it is engaged in the research and development, manufacturing, and sales of generic and branded pharmaceutical products, as well as consulting services. Its product portfolio comprises biosimilars, generic medicines, branded medicines, and various therapies in its research and development pipeline. The Group offers a differentiated portfolio of pharmaceuticals spanning several therapeutic areas, including oncology and immunology, CNS, women's health, primary care and lifestyle, and nephrology, among others. Geographically, it generates maximum revenue from the United States, and the rest from Taiwan, South Korea, Singapore, and other countries.
76GF Score
Get the complete analysis for TPE:1795
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1795 has been successfully added to your 
